GLM101

GLM101 · Glycomine, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GLM101, covering 2025-12-17 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study to Assess GLM101 in PMM2-CDG Patients [Phase 2]